Epstein-Barr virus-negative, CD5-positive diffuse large B-cell lymphoma developing after treatment with oral tacrolimus for mixed connective tissue disease : a case report and review of the literature.

Journal of clinical and experimental hematopathology : JCEH

Volumn 52, Issue 3, 2012, Pages 211-218

  Sekiguchi, Yasunobu ^a   Shimada, Asami ^b   Imai, Hidenori ^b   Wakabayashi, Mutsumi ^b   Sugimoto, Keiji ^b   Nakamura, Noriko ^b   Sawada, Tomonori ^b   Komatsu, Norio ^b   Noguchi, Masaaki ^b  

^a JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD5 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; PIRARUBICIN; PREDNISOLONE; RITUXIMAB; TACROLIMUS; VINCRISTINE;

AGED; CASE REPORT; EPSTEIN BARR VIRUS; FEMALE; GENETICS; HUMAN; IATROGENIC DISEASE; IMMUNOLOGY; LARGE CELL LYMPHOMA; MIXED CONNECTIVE TISSUE DISEASE; PATHOLOGY; REVIEW; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD5; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IATROGENIC DISEASE; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOMA, LARGE B-CELL, DIFFUSE; MIXED CONNECTIVE TISSUE DISEASE; PREDNISOLONE; SJOGREN'S SYNDROME; TACROLIMUS; VINCRISTINE;

EID: 84878418049     PISSN: None     EISSN: 18809952     Source Type: Journal    
DOI: 10.3960/jslrt.52.211     Document Type: Review

References (0)